Introduction
p53 plays a critical role in the response of cells to sources of stress such as DNA damage or hypoxia (Gottlieb and Oren, 1996; Ko and Prives, 1996; Levine, 1997) . Its ability to induce cell cycle arrest and apoptosis is due in part to its function as a sequence-specific transcriptional activator. By recognition of response elements within promoters that conform to the consensus sequence (5Ј-RRRCA/TT/ AGYYY-3Ј) 2 (el-Deiry et al., 1992) p53 can transactivate a number of target genes including, among many others, p21, Bax and cyclin G (Gottlieb and Oren, 1996; Ko and Prives, 1996; Levine, 1997) . p21 upregulation leads to cell cycle arrest by inhibiting cyclin-dependent kinase function (el-Deiry, 1993; Xiong et al., 1993; Dulic et al., 1994; Brugarolas et al., 1995) . Bax induces apoptosis by a still unknown mechanism, probably involving interaction with other members of the Bax/Bcl2 family (Oltvai et al., 1993; Yin et al., 1994; Chao and Korsmeyer, 1998) , which may modify the mitochondrial ionic potential (Gross et al., 1998; Matsuyama et al., 1998) . Cyclin G has been less well characterized but recent studies indicate that it too has pro-apoptotic activity (Okamoto, 1999) .
After stress signals there are at least two ways in which p53 is activated: its levels are increased via posttranscriptional mechanisms, and p53 protein is converted into a form that is active for DNA binding and transcriptional regulation (Gottlieb and Oren, 1996; Ko and Prives, 1996; Levine, 1997) . Several studies have suggested that multiple covalent modifications of the p53 protein are necessary to allow stabilization and/or activation of p53 (Giaccia and Kastan, 1998; Prives, 1998) . After DNA damage, p53 is inducibly phosphorylated and acetylated at a number of sites within its N-and C-termini. Phosphorylation of sites within its N-terminus are likely to affect its interactions with its negative regulator, Mdm2, as well as with components of the general transcription machinery, while phosphorylation and acetylation of sites within its C-terminus have been shown to stimulate DNA binding by p53 in vitro.
Previously we identified Ref-1 as a novel non-covalent activator of p53 (Jayaraman et al., 1997) . It was observed that Ref-1, at sub-stoichiometric concentrations, is able to convert latent p53 into a form that is activated for DNA binding in vitro. We found that Ref-1 affects the DNAbinding activity of p53 through both redox-dependent and -independent mechanisms. In fact, DNA binding by p53 has been shown previously to be strongly dependent on its redox state. Treatment of p53 with either oxidizing agents or metal chelators renders the protein incapable of DNA binding, whereas reduction of the protein enhances its DNA-binding activity (Hainaut and Milner, 1993; Delphin et al., 1994; Jayaraman et al., 1997) . Additionally, mutations in critical cysteine residues abolish or alter p53 DNA-binding activity (Rainwater et al., 1995) .
Ref-1, also known as APE-1/Hap-1/APEX, is a DNArepair (A/P) endonuclease (Demple et al., 1991; Robson and Hickson, 1991; Seki et al., 1991) that plays a central role in the process of base excision repair (BER). It functions to cleave DNA 5Ј to abasic sites, as well as to load DNA polymerase γ onto DNA (Bennett et al., 1997) . The role of Ref-1 in BER has been studied by reconstituting, in vitro, a BER system combining purified DNA polymerase γ, uracil-DNA-glycosylase, DNA ligase I and Ref-1 (Dianov and Lindahl, 1994; Nicholl et al., 1997) . Moreover, the crystal structure of Ref-1 shows strong homology with two other DNA nucleases, DNase I and Escherichia coli exonuclease III (Gorman et al., 1997) .
In addition to its roles in BER, Ref-1 was shown previously to activate the AP-1 dimeric fos-jun complex by changing the redox state of its DNA-binding domain (Xanthoudakis and Curran, 1992) . Interestingly, Ref-1 cooperates with 12-O-tetradecanoylphorbol 13-acetate (TPA) to activate AP-1 optimally, and this effect appears to be mediated by a pathway involving thioredoxin reductase and thioredoxin (Hirota et al., 1997) . The solution structure of thioredoxin and a peptide derived from Ref-1 support the existence of a physical, as well as a functional interaction between Ref-1 and thioredoxin (Qin et al., 1996) . Ref-1 increases the binding or the activity of other transcription factors, such as NF-κB, Myb (Xanthoudakis and Curran, 1992) or HIF-1 (Huang et al., 1996) , and is also a cofactor that participates in negative gene regulation after increases in intracellular calcium levels (Okazaki et al., 1994; Chung et al., 1996) .
It is of interest that Ref-1 is itself regulated by various stress signals and post-translational modifications. Hypoxia, radical oxidized species and DNA-damaging drugs were each reported to lead to increased expression of Ref-1 and/or its nuclear translocation (Yao et al., 1994; Grosch et al., 1998; Ramana et al., 1998) . Additionally, phosphorylation by casein kinase II abolishes the DNArepair function of Ref-1, presumably by regulating its exonuclease activity (Yacoub et al., 1997) .
It is a mystery why Ref-1, which is central to a critical DNA-repair process, can also affect the functioning of several seemingly disparate transcriptional regulators. Whatever the significance of its different roles in cells may be, Ref-1 is critical for early development, as deletion of the Ref-1 gene is lethal at a very early stage of embryogenesis (e5.5) (Xanthoudakis et al., 1996) . Moreover, downregulation of Ref-1 expression in Hela cells decreases clonogenic cellular survival after DNA-damaging drug treatment or hypoxia (Walker et al., 1994) . Finally, mice that are heterozygous for Ref-1 and null for p53 (and the XPG gene) manifested accelerated skin cancer after UV treatment when compared with wild-type mice (Meira et al., 1997) .
The Figure 1A) . Cells from the clone cl-R14 were co-trans-fected with a vector expressing p53 along with various reporter constructs containing one of the following p53-responsive promoters, p21-luc, Bax-luc and GADD45-luc ( Figure 1D , E and F, respectively). Induction of HA Ref-1 expression in clone cl-R14 enhanced the transcriptional activity of p53~2-fold towards the three different promoters. Similar augmentation of p53 activity was observed in the two other clones, cl-R12 and cl-R13, (data not shown), but not in a control cell line (cl-Ct) established with an empty parental vector (similar to that utilized to construct HA Ref-1) ( Figure 1B) . The increased Ref-1 protein levels had little or no effect on these reporter constructs in the absence of p53 expression, or on additional reporter genes containing CMV, SV40 or minimal c-fos promoters ( Figure 1C , and data not shown).
The ability of Ref-1 to stimulate p53 transcriptional activation was further examined using a H1299 cell line (H24-14) containing a tetracycline-regulated p53, in which induction of p53 had been shown previously to increase p21 expression and arrest the cells in G 1 and G 2 (Chen et al., 1996) . In H24-14 cells transient over-expression of HA Ref-1 augmented, in a dose-dependent fashion, the activity of a p21 promoter reporter (p21-luc) when p53 expression was induced by removal of tetracycline ( Figure 2A ). The reduction in stimulation at the highest level of Ref-1 might reflect a more general inhibitory effect, because there was a slight reduction of the p21-luc promoter activity in the absence of p53 at this dosage of Ref-1 plasmid, although at lower doses there was no significant effect of Ref-1 over-expression in the absence of p53. Note that when HA Ref-1 protein was expressed, there was a small increase in p53 protein levels ( Figure 2B ). Similar effects were observed using a reporter gene containing the 20 base pair (bp) p53 DNA-binding element from the p21 promoter (el-Deiry, 1993) upstream of the minimal c-fos promoter ( Figure 2C ; p21 min-luc). In contrast, Ref-1 had no effect on the parental vector (-53 c-fos luc) that lacks the p21-binding site ( Figure 2D ).
It was important to determine whether increasing the cellular levels of Ref-1 can enhance the ability of p53 to induce endogenously-expressed target genes. To examine this, we exploited a construct (pHook; Invitrogen, CA) that allows isolation of transfected cells. Ref-1 cDNA was cloned into this vector, which co-expresses a chimeric protein containing the transmembrane region of the PDGF receptor fused to the variable region of an antibody directed against the phOX hapten ( Figure 3A ; Materials and methods). Cells transfected with the Ref-1 or control pHook constructs were isolated on phOX magnetic beads, lysed, and p21 mRNA (Figure 3B ) or cyclin G mRNA ( Figure 3C ) levels were assessed by RT-PCR. Cyclophilin mRNA levels were used as a standard. As expected, a dramatic increase in p21 mRNA was observed after cells were induced to express p53. Moreover, when Ref-1 was over-expressed there was a further increase of~40% in p21 mRNA ( Figure 3B ). We observed that H1299 cells contain detectable levels of cyclin G mRNA in the absence of p53 ( Figure 3C ). Induction of p53, however, led to a 2-fold increase in cyclin G mRNA that was further enhanced by 50-100% upon Ref-1 expression ( Figure 3C ). Taken together our results show that elevated levels of Ref-1 in cells lead to increased transactivation by p53 of (Jayaraman et al., 1997 ; this study), there has been as yet no evidence documenting a physical 5611 interaction between the two proteins. To test this possibility we performed a 'Far-Western' assay in which Mdm2 and deleted Mdm2 (dl166) proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and renatured prior to incubation of the filter with immunopurified p53 protein ( Figure 4A ). After probing the filter with p53 antibodies, polyclonal antibodies (pAbs) 1801 and 421, we observed that p53 bound to renatured Ref-1 protein on the filter ( Figure 4B ). As controls, p53 bound to full- In these cells p21 is detected only after p53 is induced by tetracycline withdrawal (Chen et al., 1996; Figure 5A Figure 5A ). Under these conditions, downregulation of Ref-1 was correlated with dramatically reduced endogenous p21 protein levels induced by p53. Note that even at the highest concentration of antisense vector, p53 and actin levels were only modestly affected, suggesting that the main effect of loss of Ref-1 was on the activity of p53.
Since p21 is regulated by p53 at the transcriptional level (el-Deiry, 1993), we also examined p21 mRNA levels in the H24-14 p53-inducible cell line under conditions of decreased Ref-1 protein ( Figure 5B ). p21 mRNA was detected by RT-PCR and corrected by comparison with the mRNA levels of the cyclophilin gene, which is not regulated by p53. As expected, induction of p53 expression strongly increased p21 mRNA levels. When Ref-1 expression was downregulated by Ref-1 antisense, however, induction of p21 mRNA levels by p53 was reduced by 50%, as estimated by quantitation of the p21 mRNA by densitometry ( Figure 5C ). In the absence of p53 protein, Ref-1 had no effect on p21 expression.
Further support for the likelihood that the reduction of p21 mRNA levels obtained when Ref-1 was diminished involves a decrease of p53 transcriptional activity, was derived from an experiment in which p21-promoter activity in the H1299 p53-inducible cell line was analyzed by using a reporter gene assay ( Figure 6 ). While, in the presence of normal cellular levels of Ref-1, p53 strongly stimulated the activity of the transfected p21-promoter reporter gene ( Figure 6A ), the transcriptional activity of p53 was markedly reduced with increasing amounts of transfected Ref-1 antisense DNA. Under conditions where there was no detectable Ref-1 protein (e.g. Figure 5A ), the stimulation of p21-promoter activity by p53 was reduced by 60%. The transcriptional activity driven by the CMV promoter (pCMV luc) was not affected by 
Ref-1 regulates the ability of p53 to induce apoptosis
The apoptotic function of p53 is considered to be an essential component of its function as a tumor suppressor. The significance of p53-mediated apoptosis is supported by a number of studies, including the fact that several tumor-derived p53 mutants, which are defective in induction of apoptosis, display selective transcriptional activity. These mutants are able to transactivate several p53-responsive promoters, with the exception of some genes such as Bax (Friedlander et al., 1996; Rowan et al., 1996; Flaman et al., 1998; Ryan and Vousden, 1998) . Our observation that Ref-1 levels are correlated with the extent to which p53 transactivates the Bax promoter ( Figure 1C and 6B) suggested the possibility that Ref-1 might also regulate the pro-apoptotic function of p53. To test this, H1299 cells were transfected with wild-type p53 along with an expression vector that allows, via an interribosomal expression sequence (IRES), the co-expression of both the green fluorescent protein (GFP) and either the sense or the antisense Ref-1 sequence ( Figure 7A ). After transfection (72 h), the morphology of transfected cells was analyzed. An example of the morphological changes induced in cells expressing p53 is shown in Figure 7B , right panel, and an example of cells expressing a control plasmid is shown in Figure 7B , left panel. p53 overexpression induced apoptotic bodies and membrane blebbing, which are characteristic of apoptotic cells (Hale et al., 1996) . By enumerating such morphologically distinguishable cells as a function of the total GFP-expressing cells it was possible to quantify the effects of Ref-1 on the ability of p53 to induce apoptosis ( Figure 7C ). As shown previously (Haupt et al., 1995; Friedlander et al., 1996; DiComo et al., 1999) , transient transfection of wildtype p53 induced apoptosis (see Figure 7C , where the ordinate represents the percentage of apoptotic cells divided by 500 GFP-stained cells per 10-cm plate). Co-expression of p53 with Ref-1 resulted in an increase of apoptotic cells to a level~30% higher than that seen with p53 alone ( Figure 7C 
Ref-1 cooperates with camptothecin to activate p53-mediated transcription
We observed previously that administration of the topoisomerase inhibitor camptothecin (CPT) facilitates p53-mediated apoptosis in H1299 cells (Chen et al., 1996; our unpublished results) . While the mechanism of such cooperation is not yet understood, it is important to note that the levels of p53 are not affected by CPT treatment in these cells (Chen et al., 1996; and our unpublished data) . We tested the hypothesis that Ref-1 and CPT may collaborate to stimulate p53-dependent transcription. The p53-responsive p21 min-luc reporter gene, with or without co-expression of a Ref-1 expressing plasmid, was transfected into cells that had been treated or not with CPT ( Figure 8) . Interestingly, despite the unaltered levels of p53 protein, p53-dependent transcription of the reporter gene was stimulated when cells were treated with CPT. Consistent with results described in Figures 1 and 2 , Ref-1 over-expression also stimulated the p53-dependent activity of the reporter gene. Indeed, Ref-1 cooperated significantly with CPT to further induce p53 transcriptional activity.
To extend this observation, we analyzed the effect of altered Ref-1 expression in RKO cells whose endogenous wild-type p53 levels and activity are increased after DNA damage (Kessis et al., 1993; Nelson and Kastan, 1994) . The transcriptional activity of p53 was assessed using the minimal p21 promoter (p21 min-luc), transfected along with either a sense or an antisense Ref-1 vector. While 
Discussion
Ref-1 was previously discovered to be a potent activator of p53 DNA-binding activity in vitro and to stimulate the ability of p53 to transactivate a p53 reporter gene in a transient transfection assay (Jayaraman et al., 1997) some conditions. It is significant that Ref-1 augments the ability of p53 to stimulate several reporters including ones containing Bax, GADD45 and p21 promoters (this study) and the cyclin G promoter (Jayaraman et al., 1997) . These results suggest that Ref-1 may affect the overall transcriptional activity of p53, although a more extensive panel of target genes still needs to be tested before we can reach that conclusion. Ref-1 stimulates p53 activity on a reporter construct containing the minimal p53 response element from the p21 promoter, suggesting that Ref-1's effects are mediated by a p53-binding site and are not likely to involve other elements in the more complex promoters used in the other reporter constructs.
Most strikingly, we found that downregulation of Ref-1 protein levels markedly impairs the ability of p53 to induce the expression of endogenous p21. However, p21 protein levels, mRNA levels and promoter activity were not affected to similar extents by Ref-1 downregulation. p21 protein levels were almost undetectable, in contrast to its mRNA levels or promoter activity, which were reduced by~50%. This discrepancy could be due to differences in sensitivity between the assays. Alternatively, Ref-1 may affect p21 protein levels in a transcriptionindependent manner. It may be relevant that p21 expression is regulated by redox and that this involves posttranscriptional mechanisms (Esposito et al., 1997) . Downregulation of Ref-1 does not exclusively affect p21-promoter activity, as Bax expression is also reduced (Figure 6B ), implying that Ref-1 is required for optimal p53 transcriptional activity involving its other target genes. The fact that similar inhibition was obtained on both promoters (~50-60%) is in agreement with this suggestion.
The ability of p53 to induce apoptosis is affected by Ref-1 levels
By using two different assays to quantify cell apoptosis, we were able to correlate the level of Ref-1 with the induction of cell death by p53. We observed that overexpression of Ref-1 increases the ability of p53 to induce apoptosis, while downregulation of Ref-1 reduces this ability. The fact that Ref-1 downregulation does not abolish p53 induction of apoptosis may be explained by previous observations that there is a transcription-independent component of p53 function in apoptosis (Haupt et al., 1995 and references therein), including in H1299 cells (Chen et al., 1996) . It was demonstrated previously that overexpression (Tomicic et al., 1997) or downregulation (Walker et al., 1994) of Ref-1 by itself does not seem to affect cell viability, conclusions that are supported by our observations. It remains to be established whether Ref-1 can also modulate the ability of p53 to induce cell cycle arrest (G 1 /S or G 2 /M) or cell differentiation, both of which 5617 are affected by p21 levels. It is attractive to speculate that the co-involvement of Ref-1 in BER and transcriptional control of p53 may represent a tightly regulated mechanism that provokes cell cycle arrest to allow DNA repair by the BER system. The existence of such a mechanism is still hypothetical.
Ref-1 has been implicated in the clonogenic survival or the clastogenic effect after treatment with certain DNAdamaging agents (Ono et al., 1994; Walker et al., 1994; Grosch et al., 1998) . In at least one case (Walker et al., 1994) , experiments were performed in HeLa cells, which are effectively p53 null, suggesting that effects of Ref-1 exclusive of p53 are involved. In such cells, Ref-1 downregulation increased sensitivity to DNA-damaging drugs. In contrast, in our experiments apoptosis induced by p53 over-expression is decreased upon Ref-1 downregulation in H1299 cells. This discrepancy may be explained by the fact that in our case apoptosis is dependent upon p53 expression. However, DNA-damaging drugs can act upstream of p53 and may also induce p53-independent pathways that may be modulated by Ref-1. Additionally, Ref-1 has an endonuclease activity required for BER. Downregulation of Ref-1 in cells treated with DNAdamaging drugs is likely to reduce the ability of these cells to repair DNA, which can potentially lead to apoptosis.
How does Ref-1 modulate the activity of p53?
We originally identified Ref-1 through a biochemical screen for factors that can stimulate DNA binding by p53. Ref-1 was found to enhance DNA binding by wild-type p53 but not a C-terminally deleted form of p53 (p53Δ30). Similarly, Ref-1 was observed to stimulate transactivation of a reporter gene by wild-type p53, but not by p53Δ30 (Jayaraman et al., 1997) . This suggests that the in vivo effects of Ref-1 on p53 are the result of its stimulation of p53 binding to response elements within promoters, although more information is needed to confirm this possibility. In this study we further extend our knowledge about the mechanism that may allow Ref-1 to regulate p53 function by showing that Ref-1 and p53 interact in vitro and can be co-immunoprecipitated from extracts. The proportion of Ref-1 or p53 associated in vivo is low (Ͻ5%), although we cannot rule out the fact that we may not have found the optimal experimental conditions to identify a more extensive interaction between the two proteins. However, in contrast to other activators of p53, Ref-1 stimulates p53 at sub-stoichiometric ratios, which are in the catalytic range (Jayaraman et al., 1997) . Thus, very small amounts of Ref-1 may be sufficient to activate p53 in vivo. One possible way in which Ref-1 modifies the activity of its targets (c-fos, c-jun) is by altering their redox state (Xanthoudakis and Curran, 1992) , which implies an enzymatic reaction and an unstable protein interaction. Interaction of Ref-1 with c-fos was only observed after chemical or UV protein crosslinking (Xanthoudakis and Curran, 1992) . It is well established that the DNA-binding activity of p53 is strongly dependent on its redox state and that part of the stimulatory effect of Ref-1 involves a redox-dependent mechanism (Jayaraman et al., 1997) . Another possibility would be a modulation of p53 protein stability by Ref-1. Indeed, in Figure 2B , over-expression of Ref-1 slightly increases p53 protein levels. However, we observed that when Ref-1 expression was downregulated by antisense, while p53 transcriptional activity was markedly inhibited, there was no significant effect on p53 protein levels ( Figure 6 ). (Hirota et al., 1997) . Ref-1 function in that case is apparently regulated or restored by TPA via the activation of the thioredoxin reductase/thioredoxin system. Interestingly, the thioredoxin reductase gene is essential in yeast for the transcriptional activity of p53 (Casso and Beach, 1996) . Experiments examining a possible role for a signal transduction pathway involving the thioredoxin reductase/ thioredoxin system and Ref-1 are currently under way.
Materials and methods
Cell culture RKO and H1299 cells were obtained from American Type Culture Collection. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) in the presence of 5% CO 2 /95% air at 37°C. HA Ref-1 tetracycline-inducible cell lines were established as described before (Chen et al., 1996) . H24-14 (Chen et al., 1996) and HA Ref-1 stable cell lines were cultured in the presence of puromycin (2 μg/ml), neomycin (500 μg/ml) and tetracycline (5 μg/ml).
Transfection and selection of transfected cells for RT-PCR or Western blot analysis
Transfections were carried out with a lipopolyamine-based protocol (Transfectam™) as described previously (Gaiddon et al., 1994) . For reporter gene assays, cells were transfected with 400 ng of reporter gene and 400 ng of expression vector. Once transfected, cells were isolated for further analysis, transfections were performed in 10-cm plates with antisense Ref-1 pHook vector or HA Ref-1 pHook vector (10-25 μg). After 12 h, cells were washed once with phosphate-buffered saline (PBS) and incubated for 42 h in fresh medium. For further analysis, transfected cells were isolated using a Capture-Tech pHook2 system (Invitrogene™). Briefly, cells were carefully harvested into 3 ml of PBS/3 mM EDTA, centrifuged for 5 min at 800 r.p.m. and washed once with the PBS/ 3 mM EDTA buffer. Cell pellets were resuspended in 1 ml of medium including serum and then 25 μl of magnetic beads were added. Cells were slowly rocked for 45 min at 37°C and pelleted for 1 min using a magnetic strand. Pellets were resuspended into fresh medium and then cells were pelleted again in the same way. This washing step was repeated 2 to 8 times, depending on the cell type and the transfection efficiency. After the last wash, cell pellets were evaluated visually and directly lysed into mRNA extraction buffer (200 μl) (Chomczynski and Sacchi, 1987) or protein sample buffer (50 μl).
mRNA extraction and RT-PCR analysis RNA was extracted as described previously (Chomczynski and Sacchi, 1987) . Two micrograms of total RNA were used for reverse transcription reactions with 100 U of Mulerian myeloblastosis virus reverse transcriptase (Promega) in a 30 μl reaction mix containing 20 U of RNAsin (Promega), 1 mM dithiothreitol (DTT), 0.5 mM each dNTPs, 8 μM random hexamers and 1ϫ MuMLV buffer (Promega). Reaction mixtures were incubated at 42°C for 50 min and terminated by adding 70 μl H 2 O 5619 and boiling for 5 min. PCRs were performed with 3 μl of the reverse transcription products and 1 U of AmpliTaq DNA polymerase (Perkin Elmer) in a 50 μl reaction mix (including 100 μM each dNTPs, 1.5 mM Mg 2ϩ , 1ϫ AmpliTaq DNA polymerase buffer and 15 pmol of each specific primer). Typical cycle parameters were 1 min at 94°C, 1 min at 55°C and 2 min at 72°C for 15 to 35 cycles followed by a final incubation at 72°C for 10 min. Ten microliters of each reaction mixture were electrophoresed through a 2% agarose gel, and the gel was photographed and subjected to densitometric analysis. Control experiments were performed to determine the range of PCR cycles over which the amplification efficiency remains constant and proportional to the amount of input RNA. Oligonucleotides used for p21, cyclophilin and cyclin G mRNA amplifications were respectively: 5Ј-GTGGACAG-TGAGCAGTTGAG-3Ј/5Ј-GCTGGTCTGCCGCCGTTTTC-3Ј; 5Ј-GG-GGAGAAAGGATTTGGCTA-3Ј/5Ј-ACATGCTTGCCATCCAGCCA-3Ј and 5Ј-ATGACTGCAAGACTAAGGGA-3Ј/5Ј-CTTGCCAGAAGGTC-AGATCT-3Ј.
Far-Western analysis
Ref-1 and p53 proteins were purified as in Jayaraman et al. (1997) , and wild-type and dl166 Mdm2 proteins were purified as in Shieh et al. (1997) . Far-Western analysis was essentially as described (Jayaraman et al., 1998) . Proteins were subjected to SDS-PAGE, followed by transfer to nitrocellulose. After staining with Ponceau-S to identify the polypeptides, the filter was incubated in denaturation buffer (6 M guanidine-HCL in PBS) twice for 5 min at 4°C. Filters were then incubated in serial dilutions of denaturation buffer in PBS with 1 mM DTT. After blocking the membrane in PBS containing 0.5% Tween 20 and 5% non-fat dry milk (NFDM) for 45 min at 20°C the blot was washed twice with PBS/Tween 20/0.25% NFDM, and then incubated with p53 (0.2 μg/ml) in PBS containing 0.5% Tween 20, 0.25% NFDM, 1 mM DTT and 0.5% phenylmethylsulfonyl fluoride (PMSF) for 2 h. The filter was washed 4ϫ in PBS containing 0.5% Tween 20 and 0.25% NFDM, before being probed with PAb 421 as primary antibody and goat anti-mouse as secondary antibody. Proteins were detected using ECL (Amersham, IL).
Immunoprecipitation and immunoblotting
Cells were lysed in 300 μl of lysis buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 0.5% NP-40, 150 mM NaCl, 1 mM DTT, 10% glycerol, 0.5 mM PMSF, and protease inhibitor) and the extracts were centrifuged at 8000 g for 15 min to remove cell debris. Protein concentrations were determined using the Bio-Rad assay (Bio-Rad, CA). Immunoprecipitations of p53 proteins were performed by incubating 1.5 mg of wholecell extract with 100 ng of each of the following purified anti-p53 mAbs: mAb240, mAb421 and mAb1801, and rocking at 4°C for 1 h. Then, 20 μl of protein A-Sepharose beads (Pharmacia, Uppsala, Sweden) were added and the samples were rocked at 4°C for 1 h. The samples were washed 4ϫ with 1 ml of wash buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 0.5% NP-40, 1 mM DTT, 10% glycerol, 150 mM NaCl), the excess liquid was aspirated, and 30 μl of 2ϫ sample buffer (DiComo et al., 1999) were added. Samples were heated to 95°C for 5 min, centrifuged for 3 min at 13 000 g, and electrophoresed through a 10% SDS-polyacrylamide gel. Protein gels were transferred to nitrocellulose membranes (Schleicher & Schuell, NH). For p53 detection, a mixture of p53 mAb-containing supernatants (pAb421, pAb1801 and pAb240) was used, each at a 1:4 dilution. For Ref-1 detection, a pAb was used at 1:2000 dilution; for p21 detection, the Ab1 pAb (SantaCruz, CA; 1 mg/ml) was used at 1:200, and for the detection of actin a pAb (Sigma, MO) was used at a dilution of 1:200. For detection of p53 in Ref-1 immunoprecipitates, we used a secondary anti-mouse antibody that specifically recognizes the mouse κ light chain (1/1000, Pharmingen, CA). Proteins were visualized with an enhanced chemiluminescence detection system (Amersham, IL).
Expression vectors and reporter genes
The p53 expression vector (pCMVp53wt) and p21-luc, GADD45-luc and Bax-luc have been described previously (Friedlander et al., 1996) . p21-luc, Bax-luc and GADD45-luc reporters contain, respectively, the p21 promoter (2400 bp), the Bax promoter (bp -687 to -318) or fragment of GADD45 gene spanning the intronic p53-responsive element. The p21 min-luc reporter gene was prepared from oligonucleotides containing the p53-responsive sequence 5Ј-GAACATGTCCCAACATGTTG-3Ј from the p21 promoter. This sequence was inserted into a pGL3 reporter construct containing the minimal c-fos promoter (sequence from bp -53 to ϩ42) upstream of luciferase cDNA. CMV-luc contains the luciferase cDNA driven by the cytomegalovirus early promoter. A tetracycline-inducible HA Ref-1 expression vector was prepared from an HA Ref-1 PCR fragment with EcoRI and XbaI ends, inserted into the EcoRI-XbaI sites of the p10-3 vector described previously (Gossen and Bujard, 1992) . Sense and antisense HA Ref-1 pHook-expression vectors were prepared from the PCR fragment subcloned into the SmaI site of the pHook2 vector (Invitrogene, CA). Sense and antisense Ref-1 GFP vectors were prepared by insertion into an EcoRV site of the pIRES-GFP vector (Clontech, CA).
Apoptosis assays
H1299 cells in 10-cm plates were co-transfected with 7 μg of pCMVp53wt, and a construct (7 μg) containing either the Ref-1 cDNA or the antisense Ref-1 pIRES-GFP vectors (Clontech, CA). Where appropriate, 7 μg of GFP-containing IRES construct without Ref-1 sequences was included. Cells were observed under epifluorescence (Nikon, DIAPHOT 300) 72 h post-transfection and images photographed with an Optronics 3CCD video camera linked to a Macintosh computer. Under each experimental condition three plates were utilized and 500 GFP-stained cells were counted in randomly selected fields from each plate. Among the GFP-stained populations, apoptotic cells were identified by the presence of apoptotic bodies or membrane blebbing.
Cells were also subjected to FACS analysis as described by Lamm et al. (1997) . Briefly, 72 h after transfection, cells were fixed in 2% paraformaldehyde in a fixative buffer (100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 1 mM EGTA, 10 mM PIPES pH 6.8) for 20 min and then in 95% methanol for 1 h. Fixed cells were washed 3ϫ with PBS and exposed to PI (60 μg/ml) and RNase A (50 μg/ml) for 30 min before counting by FACS (FACScalibure, Becton Dickinson). Cell harvesting and FACS analysis were performed the same day to avoid loss of GFP staining. Cells (100 000) were gated for GFP staining with a 530/20 nm bandpass filter and then analyzed for DNA content (PI) with a 610 nm longpass filter. Excitation wavelength of 488 nm was used for GFP and PI. Data were analyzed using CELLQuest software (Becton Dickinson). From the DNA content profile, the sub-G 1 population of cells was gated and quantified.
